中国医学前沿杂志(电子版)
中國醫學前沿雜誌(電子版)
중국의학전연잡지(전자판)
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2014年
11期
104-106
,共3页
黄疸%维生素K%消旋山莨菪碱%凝血功能
黃疸%維生素K%消鏇山莨菪堿%凝血功能
황달%유생소K%소선산랑탕감%응혈공능
Jaundice%Vitamin K%Racanisodamine tablets%Coagulation function
目的:研究维生素K联合消旋山莨菪碱治疗小儿黄疸型肝炎临床效果,以期为临床治疗提供参考依据。方法采用随机数表法将50例黄疸型肝炎患儿分为治疗组和对照组,对照组患儿在常规黄疸型肝炎治疗基础上加用消旋山莨菪碱治疗,治疗组患儿在对照组基础上加用维生素K治疗,比较两组患儿治疗前后肝功能、凝血相关指标及疗效。结果治疗组患儿治愈19例(76.00%),显效4例(16.00%),有效2例(8.00%),无效0例(0.00%),总有效率为100.00%;对照组患儿治愈14例(56.00%),显效4例(16.00%),有效4例(16.00%),无效3例(12.00%),总有效率为88.00%,两组疗效比较差异具有显著性(P<0.05)。治疗组患儿各种症状改善率均高于对照组,但仅乏力和纳差的改善率两组比较差异具有显著性(P<0.05)。两组患儿治疗前后总胆红素、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、部分凝血活酶时间(APTT)、凝血酶原时间(PT)、血小板(PLT)水平组内比较差异具有显著性(P<0.05),治疗后治疗组患儿以上各指标改善均优于对照组,差异具有显著性(P<0.05)。结论维生素K联合消旋山莨菪碱治疗小儿黄疸型肝炎的疗效及患儿肝功能、凝血功能改善均优于常规治疗,值得临床推广应用。
目的:研究維生素K聯閤消鏇山莨菪堿治療小兒黃疸型肝炎臨床效果,以期為臨床治療提供參攷依據。方法採用隨機數錶法將50例黃疸型肝炎患兒分為治療組和對照組,對照組患兒在常規黃疸型肝炎治療基礎上加用消鏇山莨菪堿治療,治療組患兒在對照組基礎上加用維生素K治療,比較兩組患兒治療前後肝功能、凝血相關指標及療效。結果治療組患兒治愈19例(76.00%),顯效4例(16.00%),有效2例(8.00%),無效0例(0.00%),總有效率為100.00%;對照組患兒治愈14例(56.00%),顯效4例(16.00%),有效4例(16.00%),無效3例(12.00%),總有效率為88.00%,兩組療效比較差異具有顯著性(P<0.05)。治療組患兒各種癥狀改善率均高于對照組,但僅乏力和納差的改善率兩組比較差異具有顯著性(P<0.05)。兩組患兒治療前後總膽紅素、丙氨痠轉氨酶(ALT)、天鼕氨痠轉氨酶(AST)、部分凝血活酶時間(APTT)、凝血酶原時間(PT)、血小闆(PLT)水平組內比較差異具有顯著性(P<0.05),治療後治療組患兒以上各指標改善均優于對照組,差異具有顯著性(P<0.05)。結論維生素K聯閤消鏇山莨菪堿治療小兒黃疸型肝炎的療效及患兒肝功能、凝血功能改善均優于常規治療,值得臨床推廣應用。
목적:연구유생소K연합소선산랑탕감치료소인황달형간염림상효과,이기위림상치료제공삼고의거。방법채용수궤수표법장50례황달형간염환인분위치료조화대조조,대조조환인재상규황달형간염치료기출상가용소선산랑탕감치료,치료조환인재대조조기출상가용유생소K치료,비교량조환인치료전후간공능、응혈상관지표급료효。결과치료조환인치유19례(76.00%),현효4례(16.00%),유효2례(8.00%),무효0례(0.00%),총유효솔위100.00%;대조조환인치유14례(56.00%),현효4례(16.00%),유효4례(16.00%),무효3례(12.00%),총유효솔위88.00%,량조료효비교차이구유현저성(P<0.05)。치료조환인각충증상개선솔균고우대조조,단부핍력화납차적개선솔량조비교차이구유현저성(P<0.05)。량조환인치료전후총담홍소、병안산전안매(ALT)、천동안산전안매(AST)、부분응혈활매시간(APTT)、응혈매원시간(PT)、혈소판(PLT)수평조내비교차이구유현저성(P<0.05),치료후치료조환인이상각지표개선균우우대조조,차이구유현저성(P<0.05)。결론유생소K연합소선산랑탕감치료소인황달형간염적료효급환인간공능、응혈공능개선균우우상규치료,치득림상추엄응용。
Objective To study vitamin K combined with racanisodamine tablets in the treatment of infantile jaundice hepatitis clinical effect, in order to provide the reference for clinical treatment. Method 50 cases of jaundice hepatitis were randomly divided into treatment group and control group, control group based on conventional therapy jaundice hepatitis with racanisodamine tablets therapy, treatment group based on the control group with vitamin K treatment. Before and after treatment, compared two groups of related index of liver function, coagulation and curative effect. Result Treatment group 19 cases were cured (76.00%), 4 cases were markedly effective (16.00%), 2 cases were effective (8.00%), 0 cases was invalid (0.00%), the total efifciency was 100.00%;control group 14 cases were cured (56.00%), 4 cases were markedly effective (16.00%), 4 cases were effective (16.00%), 3 cases was invalid (12.00%), the total efifciency was 88.00%, the efifcacy of two groups was signiifcant (P<0.05). Treatment group in all kinds of symptom improvement rate were higher than that of control group, only weak and poor appetite improvement rate difference between the two groups were signiifcant (P<0.05). Before and after treatment, total bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), partial thromboplastin time (APTT), prothrombin time (PT), platelet (PLT) in the group the difference was signiifcant (P<0.05). Treatment group after treatment with above indexes were better than control group, the difference was signiifcant (P < 0.05). Conclusion Vitamin K combined with racanisodamine tablets in the treatment of infantile jaundice hepatitis is of better curative effect and liver function, coagulation function is better than conventional treatment, worthy of clinical application.